...
首页> 外文期刊>Therapeutic advances in respiratory disease. >Health economic modeling of the potential cost saving effects of Neurally Adjusted Ventilator Assist
【24h】

Health economic modeling of the potential cost saving effects of Neurally Adjusted Ventilator Assist

机译:神经调节式呼吸机辅助装置可能节省成本的健康经济模型

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Asynchrony between patient and ventilator breaths is associated with increased duration of mechanical ventilation (MV). Neurally Adjusted Ventilatory Assist (NAVA) controls MV through an esophageal reading of diaphragm electrical activity via a nasogastric tube mounted with electrode rings. NAVA has been shown to decrease asynchrony in comparison to pressure support ventilation (PSV). The objective of this study was to conduct a health economic evaluation of NAVA compared with PSV. We developed a model based on an indirect link between improved synchrony with NAVA versus PSV and fewer days spent on MV in synchronous patients. Unit costs for MV were obtained from the Swedish intensive care unit register, and used in the model along with NAVA-specific costs. The importance of each parameter (proportion of asynchronous patients, costs, and average MV duration) for the overall results was evaluated through sensitivity analyses. Base case results showed that 21% of patients ventilated with NAVA were asynchronous versus 52% of patients receiving PSV. This equals an absolute difference of 31% and an average of 1.7 days less on MV and a total cost saving of US$7886 (including NAVA catheter costs). A breakeven analysis suggested that NAVA was cost effective compared with PSV given an absolute difference in the proportion of asynchronous patients greater than 2.5% (49.5% versus 52% asynchronous patients with NAVA and PSV, respectively). The base case results were stable to changes in parameters, such as difference in asynchrony, duration of ventilation and daily intensive care unit costs. This study showed economically favorable results for NAVA versus PSV. Our results show that only a minor decrease in the proportion of asynchronous patients with NAVA is needed for investments to pay off and generate savings. Future studies need to confirm this result by directly relating improved synchrony to the number of days on MV.
机译:患者和呼吸机呼吸之间的不同步与机械通气(MV)持续时间的延长有关。神经调节通气辅助(NAVA)通过食管读数并通过装有电极环的鼻胃管来控制隔膜的电活动,从而控制MV。与压力支持通气(PSV)相比,NAVA已显示出减少了异步性。这项研究的目的是对NAVA和PSV进行健康经济评估。我们建立了一个模型,该模型基于改善的NAVA与PSV的同步性与同步化患者在MV上花费的时间减少之间的间接联系。 MV的单位成本是从瑞典重症监护病房登记表中获得的,并与NAVA特定成本一起用于模型中。通过敏感性分析评估了每个参数对整体结果的重要性(非同步患者的比例,成本和平均MV持续时间)。基本案例结果显示,使用NAVA通气的患者中有21%是异步的,而接受PSV的患者为52%。这等于MV的绝对差值为31%,平均减少1.7天,并且总共节省了US $ 7886(包括NAVA导管费用)。盈亏平衡分析表明,鉴于异步患者比例的绝对差异大于2.5%(分别为NAVA和PSV的异步患者分别为49.5%和52%),NAVA与PSV相比具有成本效益。基本情况的结果对于参数的变化是稳定的,例如异步差异,通气时间和每日重症监护病房成本。这项研究显示出NAVA与PSV相比在经济上具有优势。我们的结果表明,投资回报并产生储蓄​​所需的非NAVA异步患者比例仅需小幅下降。未来的研究需要通过将改善的同步性与MV天数直接相关来确认该结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号